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 S treptococcus suis (S. suis) is widely recognised in the veterinary world as a cause of rapidly progressive 
and fatal sepsis in infant pigs, associated 
with meningitis, polyarthritis, and, 
occasionally, pneumonia. A more 
fulminant bacteraemic infection is 
seen in neonatal pigs [1,2]. For reasons 
that are unknown, adult pigs do not 
succumb to this infection, although 
they demonstrate asymptomatic 
nasopharyngeal carriage (Figure 1), 
and infant piglets become infected 
after early contact with colonised 
adult females. In many respects,  S. 
suis infection is the porcine version of 
human group B strep disease. Zoonotic 
disease due to  S. suis does occur 
sporadically in Western countries, but 
is encountered more commonly in 
countries such as Thailand, China, and 
Hong Kong. It affects predominantly 
individuals with occupational exposure 
to pigs. In humans, meningitis is the 
most common presentation (about 80% 
of all cases), though  S. suis disease can 
be associated with other suppurative 
complications such as pneumonia and 
arthritis. Mortalities of 5%–10% of 
cases are reported [2], and  S. suis is the 
third most common cause of bacterial 
meningitis in Hong Kong [3].
 S. suis and Toxic Shock
 In the current issue of  PLoS Medicine, 
Tang and colleagues report on the 
largest known zoonotic outbreak of 
 S. suis , which occurred in Sichuan 
Province in China in 2005 [4]. The 
outbreak, which attracted considerable 
public and scientiﬁ c interest [5], 
killed 38 out of 204 individuals with 
the infection and coincided with a 
major outbreak of disease in pigs. In 
addition to its size and the associated 
high mortality, this outbreak is 
unique in that a large proportion 
of patients were victim to a toxic 
shock-like syndrome (TSLS). Indeed, 
the vast majority of deaths in this 
outbreak occurred in patients with 
TSLS rather than in patients with 
meningitis. To date, streptococcal 
toxic shock, per consensus deﬁ nition, 
has been limited to disease caused 
by the group A streptococcus,  S. 
pyogenes [6]. Sporadic reports of TSLS 
due to other (nongroup A) beta-
haemolytic streptococci have been 
reported, though there is potentially 
considerable diagnostic overlap 
between cases of septic shock and 
TSLS [7]. With one exception [8],  S. 
suis has not previously been linked to 
TSLS. Tang and colleagues report that 
almost all human cases of TSLS due to 
 S. suis demonstrated an erythematous 
blanching rash, one of the most speciﬁ c 
features of TSLS, associated with 
hypotension and multiorgan failure. 
Tang and colleagues provide insight 
into the clinical outbreak with regard 
to the spectrum of clinical disease, 
morbidity, and mortality. They did not 
identify a clear focus of infection in the 
TSLS cases, in contrast to the originally 
described streptococcal toxic shock 
syndrome, where soft tissue infection 
was most commonly found.
 S. suis —The Source? 
 Epidemiologically, all cases of human 
disease in the recent outbreak were 
linked to exposure to pigs, and, 
although broken skin is reported 
in most cases, the precise route of 
transmission is not further discussed. 
Other sporadic zoonotic  S. suis 
cases have been linked to accidental 
inoculation injuries through lacerations 
or inhalation of infected aerosols from 
infected carcasses, though  S. suis is 
also found in faeces and fomites of 
infected herds [1,2]. At least some of 
the human cases in an earlier  S. suis 
outbreak in Sichuan Province in 1998 
may have been related to ingestion 
of contaminated food [9]. Farmers in 
Sichuan Province have close contact 
with their pigs; humans and animals 
often share the same accommodations 
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and animals are slaughtered at home. 
Furthermore, it is common practice for 
diseased animals to be slaughtered and 
eaten. Thus, in addition to inoculation 
and airborne transmission from 
infected pigs, foodborne transmission 
by infected pork may have also 
contributed to the recent outbreak. 
 Phenotype of Virulent  S. suis 
Isolates: Lack of Superantigenicity?
 Having identiﬁ ed  S. suis as the 
causative agent of the 2005 outbreak, 
the authors went on to provide an 
initial phenotypic and molecular 
analysis of the  S. suis strains involved in 
clinical disease. Bacterial superantigen 
production, with consequent 
overstimulation of immunological 
cascades, is believed to underlie the 
catastrophic features of toxic shock 
[10]. However, little is known about 
the superantigenicity of  S. suis , and 
when Tang and colleagues tested  S. 
suis isolates for mitogenic activity, a 
hallmark of superantigen production, 
they found none. In the absence of 
superantigens, alternative virulence 
mechanisms might account for 
endothelial leakage and the features 
of TSLS, such as M protein–ﬁ brinogen 
interactions and activation of the 
coagulation system [10,11]. More 
detailed analysis of the strains 
associated with the outbreak is required 
to eliminate a role for superantigens; 
this includes molecular analysis and 
study of T cell subset changes induced 
by exposure to secreted products of 
these strains. The genome sequences of 
two  S. suis strains are currently available 
for study (see http:⁄⁄www.sanger.ac.uk/
Projects/S_suis and http:⁄⁄genome.
jgi-psf.org/draft_microbes/strsu/strsu.
home.html), and although regions 
bearing some similarity to  S. pyogenes M 
protein and superantigen genes can be 
identiﬁ ed, functional analysis is needed 
to fully characterise these features. 
 In Vivo Study of  S. suis Virulence
 One of the key questions arising from 
this report is whether a new, highly 
virulent strain of  S. suis has emerged in 
China? Tang and colleagues explored 
virulence using a neonatal piglet 
model of infection. Consistent with its 
causative role, the  S. suis strain from 
the recent outbreak caused disease, 
whereas a known avirulent  S. suis strain 
did not. Future studies might be best 
served by a comparison of invasive 
isolates from the current outbreak 
with those causing invasive disease 
in other countries, in addition to a 
comparison with colonising isolates. 
Being the natural host, the pig is 
clearly a superior model for study of  S. 
suis, and mouse models have proved 
unreliable [12]. Future reﬁ nement and 
standardisation of  S. suis models should 
include the use of pathogen-free piglets 
and the administration of an inoculum 
via the nasopharyngeal route, in order 
to better reproduce natural infection. 
Pigs are normally sensitive to the effects 
of superantigens [13], although they 
have not been reported to develop the 
rash characteristic of human TSLS. 
 Comparison of Chinese Outbreak 
Isolates with Other Virulent Strains
 To compare the  S. suis isolates of the 
Chinese outbreak with European 
invasive isolates, molecular analysis 
was undertaken by the investigating 
team.  S. suis is an alpha-haemolytic, or 
nonhaemolytic, group D streptococcus, 
which is normally sensitive to penicillins 
in vitro. Strains associated with virulent 
disease do produce a number of 
extracellular proteins, such as a 110-
kDa extracellular factor, a 136-kDa 
muramidase-released protein, and a 
thiol-activated haemolysin (suilysin), 
although none alone are sufﬁ cient 
for full virulence [14]. The capsular 
polysaccharide, as for other streptococci, 
appears crucial to resistance to 
opsonophagocytosis [15]. There are 
35 known capsular serotypes, though 
capsular serotype 2—the type associated 
with the 2005 outbreak in China—is 
the most common in most parts of 
the world. Even within this serotype, 
there is heterogeneity, and European 
strains appear more likely to produce 
virulence-associated exoproteins than 
North American strains [14]. Isolates 
from the 2005 outbreak in Sichuan 
Province were compared at a molecular 
level with a European serotype-2 strain 
(P1/7) and with a handful of isolates 
from the earlier outbreak in Sichuan 
Province in 1998. 
 The isolates from the recent Chinese 
outbreak carried genes for all of the 
known virulence-associated factors, 
akin to European invasive strains. 
However, Tang and colleagues report 
that the serotype-2 strain associated 
with the recent outbreak is quite 
different to other invasive type-2 
isolates with regard to the capsular 
polysaccharide synthesis gene cluster 
and restriction fragment length 
polymorphism pattern. Intriguingly, 
the recent isolates are indistinguishable 
from the isolates that caused the earlier 
1998 outbreak in China that killed 14 
out of 25 human patients [9]. Thus, 
there appears to be good evidence that 
the strains from the Chinese outbreaks 
are epidemiologically distinct from 
other invasive  S. suis strains. 
 Emerging  S. suis Infections in 
Humans: A Need for Coordinated 
and Cooperative Research
 S. suis infection is of major economic 
and veterinary importance in the 
farming world, and should now be on 
the list of differential diagnoses when 
clinicians encounter patients with 
unexplained sepsis who have a history 
of exposure to pigs. Eradication of 
 S. suis from the pig population is not 
currently feasible, even though  S. suis 
appears fully sensitive to penicillin. 
Antibiotic treatment in pigs is rarely 
successful, probably because of 
poor antibiotic penetration of the 
porcine tonsillar tissues, which act as 
a source of infection [16]. Resistance 
to macrolides, lincosamides, and 
tetracycline is common, limiting efforts 
to clear tonsillar carriage. Development 
of a vaccine targeted against the 
most virulent or prevalent strains 
might be one possible way to prevent 
colonisation of female pigs and to 
protect those working with pigs [17]. 
Better characterisation of activities 
that increase risk of  S. suis acquisition 
and faster diagnostic tests to identify 
outbreaks in pigs will lead to adaptation 
of practices that incur unnecessary 
exposure to infected carcasses.
 The emergence of any new zoonotic 
infectious disease associated with high 
DOI: 10.1371/journal.pmed.0030187.g002
 Figure 1. Scanning Electron Microscopy of 
 S. suis Diplococci in a Sheet of Mucus on the 
Surface of the Nasopharyngeal Epithelium 
from a Pig
 (Photo: Josh D. Slater) 
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mortality is of global concern, and 
there is an urgent need for better 
characterisation of the  S. suis strains 
involved. Whether the Chinese strain 
has enhanced virulence per se is at 
present unclear; the increased mortality 
seen with the two Chinese outbreaks 
may simply reﬂ ect regional differences 
in mode of acquisition or in access to 
treatment. International collaboration 
between laboratories experienced 
in virulence analysis and molecular 
epidemiology is required in order to 
clarify differences between isolates 
circulating in different regions of the 
world.  
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